Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bob Swift who wrote (1863)	3/4/1999 7:46:00 PM
From: Don Miller	Read Replies (1) of 10280

Good questions Bob, I have followed this stock across three boards and I still have one question that furthers Bob's thread. Please let me introduce myself to this board, I'm a chemical engineer and a stock holder. I was introduced at 36 and told to wait for a drop to 25, got dumber by 44, smarter at 56, disbeliever at 86, convinced at 96, annoyed with myself by 125. But here for the duration. This by far the best thread I have seen. My question has burnt a $60 (membership) hole in my pocket today. When you have a front runner in the market place everbody constantly is trying to do your achievement one better. In the specialty chemical industry typically the front running (or best) compound has a half life that is well short of the patent term. I'm new to pharms. I suspect that drugs in general have a similar pattern, probably even shorter leadership due to higher profit margins. On other boards I have seen this stock valued on one year earning of just one patent. Can anybody tell me what the statical average duration is for the front running drug in the high profit margin areas? Can anybody tell me how this should impact the PV of this stock?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next